Loading…
← CockpitCompetitor Analysis › TRLV Trulieve Cannabis Corp.Open in the cockpit ↗

Trulieve Cannabis Corp.TRLVCompetitor analysis, valuation and peers

United States · USD·Consumer Staples›Agricultural Commodities/Milling

US multi-state cannabis operator running dispensaries and cultivation facilities, with a leading position in Florida.

Momentum strong 70
Mkt cap
$1.93B
US dollars, full cap
Free float
96%
of shares outstanding
$/day
$15.3M
20-day average traded
Fwd P/E
28.5×
forward earnings
ROIC−WACC
+0.0 pp
WACC 12.5%
Hurdle
-7 pp
Req g minus delivered
Next earnings
106 days
4 Mar 2027
Close · USD$10.02
1D-0.5%
1W-10.8%
1M-7.1%
3M-2.2%
6M+25.4%
YTD+15.3%
1Y+92.7%
ATR %6.9%
Beta0.67
52w lowhigh24.6% off high

What Trulieve Cannabis does

US multi-state cannabis operator running dispensaries and cultivation facilities, with a leading position in Florida.

Grows, makes and sells its own products through its own dispensaries, because Florida's licence rules require that vertical integration. Cannabis is still illegal under US federal law, so tax rule 280E bars most normal business deductions, raising its tax bill. It acquired Harvest Health in 2021 to reach more states.

Products and services

  • Retail cannabis dispensaries
  • Cannabis cultivation/processing
  • Branded cannabis products

Customers

  • Medical and (where legal) adult-use cannabis consu

Where it sits in the supply chain

  • Consumer staples
  • Cannabis cultivation & retail
  • Multi-state dispensary operations

What could go right

  • State-by-state cannabis legalization/expansion
  • Potential federal rescheduling

What could go wrong

  • Heavy federal tax burden (280E)
  • Regulatory/legalization uncertainty

Moat: narrow (regulatory licence, scale, brand). State cannabis licenses are limited and hard to obtain, especially its dominant Florida position.

Headquarters: Tallahassee, Florida, US · Founded: 2014 · Employees: 5,000

Named competitors

  • Curaleaf Holdings CURA.TO
  • Green Thumb Industries private or unlisted
  • Verano Holdings private or unlisted
  • Cresco Labs private or unlisted
  • TerrAscend private or unlisted
  • Ayr Wellness private or unlisted
  • Glass House Brands private or unlisted

Trulieve Cannabis at a glance

Size Trulieve Cannabis (TRLV) is a United States Consumer Staples company (Agricultural Commodities/Milling) with a market value of $1.93B, the 1797th largest of 3,085 United States companies the cockpit tracks. Shares closed at $10.02 on 18 Nov 2026.

Performance Over six months the shares gained 25.4%, against -13.1% for the median peer and -2.2% for the United States market (cap-weighted) — 3rd highest of 20 in its peer set.

Growth Revenue fell 9.1% over the last twelve months (peer median +4.3%); the operating margin is 15.1% (peer median 5.9%).

Valuation It trades at 28.5× forward earnings against a peer median of 17.2× (3rd most expensive of 14).

Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -7 pp: the price already allows for a slowdown.

Capital Return on invested capital runs 0.0 points above its cost of capital (12.5% WACC).

Short interest Short interest is 2.3% of the free float (30 Oct 2026).

Next results Next results expected around 4 Mar 2027 (exchange calendar; dates can move).

Relative performance

10012515021 May 202621 Aug 202618 Nov 2026TRLV 127Peer median 88
Six months, rebased to 100: Trulieve Cannabis against the median of its 20 peers (local-currency closes).

Trulieve Cannabis financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.08B$1.18B$1.19B$1.13B$1.22B
Revenue growth—0%+5%-7%—
Gross profit$553M$594M$603M$479M$573M
EBITDA$320M$332M$270M$259M$289M
Net income-$446M-$116M-$155M-$527M-$246M
Free cash flow$172M$229M$149M$161M-$155M
Capital expenditure$65.7M$60.5M$148M$55.6M$189M
Total debt$582M$564M$824M$429M$433M

Quarterly statements and history in the cockpit →

Trulieve Cannabis competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%-25%0%+25%+50%-20%0%000833BIOMARGNS002385CURAUIE1229002100000998BFG6019522607P8ZLTFOODS1117605296002458TRLV6-month return →1-month return →
Up and to the right = strong over both horizons. Trulieve Cannabis is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%25×50×75×000833BIOMARGNS000998BFG2607P8ZAWLLTFOODS000061TRLVRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Trulieve Cannabis is the large dot.

Capital: growth delivered against growth the price implies

-20%-10%0%+10%+20%-20%0%20%000833BIOMARGNSUIE12296019522607P8ZAWLLTFOODS000061002458TRLVGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Trulieve Cannabis is the large dot.

Trulieve Cannabis competitors and peer comparison

Head to head with its named competitors (TRLV vs CURA.TO)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Trulieve Cannabis TRLV$1.93B+25%-9%15%28.5×11.2%
Curaleaf CURA.TO$2.10B-17%+5%1%n/an/a

How Trulieve Cannabis compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Trulieve Cannabis against its 20 peers (data as of 18 Nov 2026)
MeasureTRLVPeer medianRank in peer set
1-month return-7.1%-4.0%6th lowest of 21
6-month return+25.4%-13.1%3rd highest of 20
Distance from 52-week high-24.6%-32.0%9th highest of 21
Revenue growth (TTM)-9.1%+4.3%2nd lowest of 21
Operating margin15.1%5.9%6th highest of 21
Forward P/E28.5×17.2×3rd most expensive of 14
Growth the price implies (Req g, 7 yrs)11.2%1.9%5th most demanding of 13
Growth delivered (Del g)+17.8%+12.0%2nd highest of 13
Hurdle (Req g minus delivered)-6.6 pp-3.4 pp5th least demanding of 13
ROIC minus cost of capital+0.0 pp-2.1 pp9th highest of 21
EV / EBITDA6.8×11.5×2nd cheapest of 9
Net debt / EBITDA0.8×1.8×5th least indebted of 11

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Trulieve Cannabis TRLVUnited States$1.93B+25%-9%15%28.5×11.2%+17.8%
Guangxi Yuegui Guangye 000833.SZChina$1.96B-46%+67%30%8.6×0.4%-0.9%
BioMar Group A/S BIOMAR.CODenmark$1.85B-31%0%6%13.6×-1.2%-0.5%
Genus GNS.LUnited Kingdom$1.81B-13%-2%13%21.2×16.1%+2.8%
Beijing Dbn Technology 002385.SZChina$1.78B-22%-1%-6%n/an/an/a
Curaleaf CURA.TOCanada$2.10B-17%+5%1%n/an/an/a
Uie UIE.CODenmark$1.71B+8%+11%40%n/a-15.2%+13.1%
Lien Hwa Industrial 1229.TWTaiwan$2.20B+2%+1%19%n/a12.0%+7.3%
Tecon Biology 002100.SZChina$1.69B+14%-8%-5%n/an/an/a
Yuan Longping High-Tech Agriculture 000998.SZChina$1.65B-14%-5%5%43.5×n/an/a
B.F BFG.MIItaly$2.26B+59%+30%-2%85.0×n/an/a
Jiangsu Provincial Agricultural Reclamation & Dev 601952.SSChina$1.63B-13%-5%4%19.0×-2.9%+3.2%
Fuji Oil 2607.TJapan$2.30B+24%+4%5%14.4×0.4%+16.2%
Bumitama Agri P8Z.SISingapore$1.61B-28%+9%25%8.9×-16.8%+12.9%
AWL Agri Business AWL.NSIndia$2.38B-15%+18%2%18.0×13.9%+15.0%
LT Foods LTFOODS.NSIndia$1.56B+2%+24%8%12.8×25.8%+18.2%
Shenzhen Agricultural Products 000061.SZChina$1.52B-22%-22%12%24.4×3.5%+15.6%
China Modern Dairy 1117.HKHong Kong$1.50B+29%+5%-15%13.7×n/an/a
Liuliumei 6658.HKHong Kong$1.46Bn/a+6%12%n/an/an/a
Yunnan Shennong Agricultural Industry 605296.SSChina$2.57B+10%+2%-19%n/an/an/a
Shandong Yisheng Livestock & Poultry Breeding 002458.SZChina$1.44B-25%+15%17%17.2×5.4%+11.1%

Questions

Who are Trulieve Cannabis's main competitors?
Named competitors: Curaleaf Holdings (CURA.TO), Green Thumb Industries (private or unlisted), Verano Holdings (private or unlisted), Cresco Labs (private or unlisted), TerrAscend (private or unlisted), Ayr Wellness (private or unlisted). The cockpit's measured peer set (industry) also includes Guangxi Yuegui Guangye (000833.SZ), BioMar Group A/S (BIOMAR.CO), Genus (GNS.L), Beijing Dbn Technology (002385.SZ), Curaleaf (CURA.TO), Uie (UIE.CO).
Is Trulieve Cannabis expensive compared with its peers?
On forward p/e it trades at 28.5× against a peer median of 17.2×, 3rd most expensive of 14 in its peer set. For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +18%, so the hurdle is -7 pp: the price already allows for a slowdown.
How has Trulieve Cannabis stock performed?
Over six months to 18 Nov 2026 the shares returned +25.4% against -13.1% for the median peer; over one year +92.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.